Detalhe da pesquisa
1.
Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria.
Histopathology
; 82(6): 837-845, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645163
2.
The prognostic value of lymph node staging with prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node-positive patients with prostate cancer.
BJU Int
; 131(3): 330-338, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069585
3.
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.
BJU Int
; 132(2): 170-180, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748180
4.
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
Histopathology
; 81(4): 447-458, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758185
5.
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival.
World J Urol
; 39(12): 4363-4371, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196758
6.
Gleason grade patterns in nodal metastasis and corresponding prostatectomy specimens: impact on patient outcome.
Histopathology
; 75(5): 715-722, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31177561
7.
Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web-based survey by the European Network of Uropathology.
Histopathology
; 74(6): 844-852, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30604878
8.
Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 75(4): 453-467, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31009090
9.
Predicting biochemical recurrence and prostate cancer-specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening- and clinically detected prostate cancer.
BJU Int
; 124(4): 635-642, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31055875
10.
SIU-ICUD on bladder cancer: pathology.
World J Urol
; 37(1): 41-50, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30218308
11.
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 Years.
J Urol
; 200(5): 1056-1061, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29758220
12.
Utility of Pathology Imagebase for standardisation of prostate cancer grading.
Histopathology
; 73(1): 8-18, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29359484
13.
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.
BJU Int
; 122(6): 978-985, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29637669
14.
Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.
Int J Urol
; 24(4): 281-286, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28173626
15.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Lancet
; 384(9959): 2027-35, 2014 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25108889
16.
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.
Mod Pathol
; 28(5): 695-705, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25431236
17.
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.
Mod Pathol
; 28(5): 612-30, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25412849
18.
Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder.
Curr Opin Urol
; 25(5): 427-35, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26125511
19.
Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
Prostate
; 74(5): 488-96, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375374
20.
Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists.
Histopathology
; 65(2): 216-27, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24467262